Defining the blanks - Pharmacochaperoning of SLC6 transporters and ABC transporters

Pharmacological Research

Volumn 83, Issue , 2014, Pages 63-73

  Chiba, Peter ^a   Freissmuth, Michael ^a   Stockner, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

ABC transporters; Chaperones; ER export; Folding deficient mutants; Pharmacochaperoning; SLC6 transporters

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; 4 PHENYLBUTYRIC ACID; ABC TRANSPORTER; CHAPERONE; CHENODEOXYCHOLIC ACID; CHLORIDE CHANNEL AFFECTING AGENT; CID 10133; CID 11957831; CID 5284373; CID 9893571; COATOMER PROTEIN; COATOMER PROTEIN 2; CYCLOSPORIN A; DOPAMINE TRANSPORTER; GABA TRANSPORTER 1; GABA TRANSPORTER 2; GABA TRANSPORTER 3; GLYCINE TRANSPORTER 1; GLYCINE TRANSPORTER 2; IVACAFTOR; LUMACAFTOR; NORADRENALIN TRANSPORTER; PHARMACOCHAPERONE; SEROTONIN TRANSPORTER; SMALL MOLECULE TRANSPORT AGENT; TAURINE TRANSPORTER; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG; VRT 325; CARRIER PROTEIN; LIGAND;

ARTICLE; ENDOPLASMIC RETICULUM; FAMILIAL DISEASE; GENE; GENE MUTATION; GENETIC CODE; HUMAN; INTRAHEPATIC CHOLESTASIS; PRIORITY JOURNAL; PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 2; PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 3; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MOTIF; SLC6A1 GENE; SLC6A11 GENE; SLC6A12 GENE; SLC6A13 GENE; SLC6A14 GENE; SLC6A15 GENE; SLC6A16 GENE; SLC6A17 GENE; SLC6A18 GENE; SLC6A19 GENE; SLC6A2 GENE; SLC6A20 GENE; SLC6A3 GENE; SLC6A4 GENE; SLC6A5 GENE; SLC6A6 GENE; SLC6A7 GENE; SLC6A8 GENE; SLC6A9 GENE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; GENETICS; MUTATION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; DRUG DISCOVERY; HUMANS; LIGANDS; MEMBRANE TRANSPORT PROTEINS; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION; PROTEIN FOLDING;

EID: 84901938488     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2013.11.009     Document Type: Article

References (108)

1. B.J. Strasser Perspectives: molecular medicine, sickle cell anemia, a molecular disease Science 286 1999 1488 1490
2. A. Garrod The lessons of rare maladies Lancet 211 5465 1928 1055 1060
3. C. Levinthal How to fold graciously J.T.P. DeBrunner, E. Munck, Mössbauer spectroscopy in biological systems 1969 University of Illinois Press Allerton House, Monticello, IL 22 24
4. E. Park, and T.A. Rapoport Mechanisms of Sec61/SecY-mediated protein translocation across membranes Annu Rev Biophys 41 2012 21 40
5. T. Hessa, N.M. Meindl-Beinker, A. Bernsel, H. Kim, Y. Sato, and M. Lerch-Bader et al. Molecular code for transmembrane-helix recognition by the Sec61 translocon Nature 450 2007 1026 1030 (Pubitemid 350273612)
6. I.T. Arkin, and A.T. Brunger Statistical analysis of predicted transmembrane a-helices Biochim Biophys Acta 1429 1998 113 128 (Pubitemid 29052215)
7. H.A. Lester, J.M. Miwa, and R. Srinivasan Psychiatric drugs bind to classical targets within early exocytotic pathways: therapeutic effects Biol Psychiatry 72 2012 907 915
8. M.K. Hahn, D. Robertson, and R.D. Blakely A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters J Neurosci 23 2003 4470 4478 (Pubitemid 36706177)
9. M.K. Hahn, M.S. Mazei-Robison, and R.D. Blakely Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation Mol Pharmacol 68 2005 457 466 (Pubitemid 41058309)
10. M.S. Mazei-Robison, and R.D. Blakely Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala Neuropharmacology 49 2005 737 749 (Pubitemid 41483880)
11. M.S. Mazei-Robison, R.S. Couch, R.C. Shelton, M.A. Stein, and R.D. Blakely Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder Neuropharmacology 49 2005 724 736 (Pubitemid 41483879)
12. M.S. Mazei-Robison, E. Bowton, M. Holy, M. Schmudermaier, M. Freissmuth, and H.H. Sitte et al. Anomalous dopamine release associated with a human dopamine transporter coding variant J Neurosci 28 2008 7040 7046
13. P.J. Hamilton, N.G. Campbell, S. Sharma, K. Erreger, F. Herborg Hansen, and C. Saunders et al. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder Mol Psychiatry 18 2013 1315 1323
14. D. Sakrikar, M.S. Mazei-Robison, M.A. Mergy, N.W. Richtand, Q. Han, and P.J. Hamilton et al. Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation J Neurosci 32 April 2012 5385 5397
15. M.A. Kurian, J. Zhen, S.-Y. Cheng, Y. Li, S.R. Mordekar, and P. Jardine et al. Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia J Clin Invest 11 2009 1595 1603
16. M.A. Kurian, Y. Li, J. Zhen, E. Meyer, N. Hai, and H.J. Christen et al. Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study Lancet Neurol 10 2011 54 62
17. J.S. Sutcliffe, R.J. Delahanty, H.C. Prasad, J.L. McCauley, Q. Han, and L. Jiang et al. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors Am J Hum Genet 77 2005 265 279 [Epub 2005 Jul 1] (Pubitemid 41022709)
18. N. Ozaki, D. Goldman, W.H. Kaye, K. Plotnicov, B.D. Greenberg, and J. Lappalainen et al. Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype Mol Psychiatry 8 2003 933 936 (Pubitemid 37421700)
19. F. Kilic, D.L. Murphy, and G. Rudnick A human serotonin transporter mutation causes constitutive activation of transport activity Mol Pharmacol 64 August (2) 2003 440 446 (Pubitemid 36910008)
20. E. Voyiaziakis, O. Evgrafov, D. Li, H.J. Yoon, P. Tabares, and J. Samuels et al. Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study Mol Psychiatry 16 2011 108 120
21. M.I. Rees, K. Harvey, B.R. Pearce, S.K. Chung, I.C. Duguid, and P. Thomas et al. Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease Nat Genet 38 2006 801 806 (Pubitemid 43980601)
22. V. Eulenburg, K. Becker, J. Gomeza, B. Schmitt, C.M. Becker, and H. Betz Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia Biochem Biophys Res Commun 348 2006 400 405 (Pubitemid 44188585)
23. E. Carta, S.K. Chung, V.M. James, A. Robinson, J.L. Gill, and N. Remy et al. Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease J Biol Chem 287 2012 28975 28985
24. C. Giménez, G. Pérez-Siles, J. Martínez-Villarreal, E. Arribas-González, E. Jiménez, and E. Núñez et al. A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2 J Biol Chem 287 2012 28986 29002
25. M. Vincent, C. Collet, A. Verloes, L. Lambert, C. Herlin, and C. Blanchet et al. Large deletions encompassing the TCOF1 and CAMK2A genes are responsible for Treacher Collins syndrome with intellectual disability Eur J Hum Genet 2013 [in press]
26. G.S. Salomons, S.J. van Dooren, N.M. Verhoeven, K.M. Cecil, W.S. Ball, and T.J. Degrauw et al. X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome Am J Hum Genet 68 2001 1497 1500 (Pubitemid 32510625)
27. E.H. Rosenberg, L.S. Almeida, T. Kleefstra, R.S. deGrauw, H.G. Yntema, and N. Bahi et al. High prevalence of SLC6A8 deficiency in X-linked mental retardation Am J Hum Genet 75 2004 97 105 (Pubitemid 38801905)
28. V. Valayannopoulos, N. Bakouh, M. Mazzuca, L. Nonnenmacher, L. Hubert, and F.L. Makaci et al. Functional and electrophysiological characterization of four non-truncating mutations responsible for creatine transporter (SLC6A8) deficiency syndrome J Inherit Metab Dis 36 2013 103 112
29. J.M. van de Kamp, O.T. Betsalel, S. Mercimek-Mahmutoglu, L. Abulhoul, S. Grünewald, and I. Anselm et al. Phenotype and genotype in 101 males with X-linked creatine transporter deficiency J Med Genet 50 2013 463 472
30. T. Inada, M. Koga, H. Ishiguro, Y. Horiuchi, A. Syu, and T. Yoshio et al. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia Pharmacogenet Genomics 18 2008 317 323 (Pubitemid 351367525)
31. H.J. Park, J.W. Kim, S.K. Lee, S.K. Kim, J.K. Park, and A.R. Cho et al. Association between the SLC6A12 gene and negative symptoms of schizophrenia in a Korean population Psychiatry Res 189 2011 478 479
32. C.F. Pasaje, J.H. Kim, B.L. Park, H.S. Cheong, J.Y. Chun, and T.J. Park et al. Association of SLC6A12 variants with aspirin-intolerant asthma in a Korean population Ann Hum Gene 74 2010 326 334
33. A. Köttgen, C. Pattaro, C.A. Böger, C. Fuchsberger, M. Olden, and N.L. Glazer et al. New loci associated with kidney function and chronic kidney disease Nat Genet 42 2010 376 384
34. L. Sun, J.M. Rommens, H. Corvol, W. Li, X. Li, and T.A. Chiang et al. Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis Nat Genet 44 2012 562 569
35. E. Suviolahti, L.J. Oksanen, M. Ohman, R.M. Cantor, M. Ridderstrale, and T. Tuomi et al. The SLC6A14 gene shows evidence of association with obesity J Clin Invest 112 2003 1762 1772 (Pubitemid 38063734)
36. E. Durand, P. Boutin, D. Meyre, M.A. Charles, K. Clement, and C. Dina et al. Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians Diabetes 53 2004 2483 2486 (Pubitemid 39145608)
37. C. Quast, S. Cuboni, D. Bader, A. Altmann, P. Weber, and J. Arloth et al. Functional coding variants in SLC6A15, a possible risk gene for major depression PLoS ONE 8 2013 e68645
38. S. Bröer, C.G. Bailey, S. Kowalczuk, C. Ng, J.M. Vanslambrouck, and H. Rodgers et al. Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters J Clin Invest 118 2008 3881 3892
39. R. Kleta, E. Romeo, Z. Ristic, T. Ohura, C. Stuart, and M. Arcos-Burgos et al. Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder Nat Genet 36 2004 999 1002 (Pubitemid 39167498)
40. H.F. Seow, S. Bröer, A. Bröer, C.G. Bailey, S.J. Potter, and J.A. Cavanaugh et al. Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19 Nat Genet 36 2004 1003 1007 (Pubitemid 39167499)
41. D.N. Azmanov, S. Kowalczuk, H. Rodgers, C. Auray-Blais, R. Giguère, and J.E. Rasko et al. Further evidence for allelic heterogeneity in Hartnup disorder Hum Mutat 29 2008 1217 1221
42. S. Kowalczuk, A. Bröer, N. Tietze, J.M. Vanslambrouck, J.E. Rasko, and S. Bröer A protein complex in the brush-border membrane explains a Hartnup disorder allele FASEB J 22 2008 2880 2887
43. S.M. Camargo, D. Singer, V. Makrides, K. Huggel, K.M. Pos, and C.A. Wagner et al. Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations Gastroenterology 136 2009 872 882
44. J.A. Schmid, P. Scholze, O. Kudlacek, M. Freissmuth, E.A. Singer, and H.H. Sitte Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells J Biol Chem 276 2001 3805 3810
45. T. Stockner, T.R. Montgomery, O. Kudlacek, R. Weissensteiner, G.F. Ecker, and M. Freissmuth et al. Mutational analysis of the high-affinity zinc binding site validates a refined human dopamine transporter homology model PLoS Comput Biol 9 2013 e1002909
46. Y. Zhao, D. Terry, L. Shi, H. Weinstein, S.C. Blanchard, and J.A. Javitch Substrate-dependent proton antiport in neurotransmitter:sodium symporters Nature 465 2010 188 193
47. S. Keuerleber, I. Gsandtner, and M. Freissmuth From cradle to twilight: the carboxyl terminus directs the fate of the A(2A)-adenosine receptor Biochim Biophys Acta 1808 2011 1350 1357
48. P. Scholze, M. Freissmuth, and H.H. Sitte Mutations within an intramembrane leucine heptad repeat disrupt oligomer formation of the rat GABA transporter 1 J Biol Chem 277 2002 43682 43690 (Pubitemid 36157784)
49. V.M. Korkhov, H. Farhan, M. Freissmuth, and H.H. Sitte Oligomerization of the ?-aminobutyric acid transporter-1 is driven by an interplay of polar and hydrophobic interactions in transmembrane helix II J Biol Chem 279 2004 55728 55736 (Pubitemid 40066579)
50. H. Farhan, V.M. Korkhov, V. Paulitschke, M.M. Dorostkar, P. Scholze, and O. Kudlacek et al. Two discontinuous segments in the carboxyl terminus are required for membrane targeting of the rat ?-aminobutyric acid transporter-1 (GAT1) J Biol Chem 279 2004 28553 28563 (Pubitemid 38900138)
51. H. Just, H.H. Sitte, J.A. Schmid, M. Freissmuth, and O. Kudlacek Identification of an additional interaction domain in transmembrane domains 11 and 12 that supports oligomer formation in the human serotonin transporter J Biol Chem 279 2004 6650 6657 (Pubitemid 38248803)
52. V.M. Korkhov, L. Milan-Lobo, B. Zuber, H. Farhan, J.A. Schmid, and M. Freissmuth et al. Peptide-based interactions with calnexin target misassembled membrane proteins into endoplasmic reticulum-derived multilamellar bodies J Mol Biol 378 2008 337 352
53. C.G. Tate, E. Whiteley, and M.J. Betenbaugh Molecular chaperones stimulate the functional expression of the cocaine-sensitive serotonin transporter J Biol Chem 274 1999 17551 17558
54. H. Farhan, V. Reiterer, V.M. Korkhov, J.A. Schmid, M. Freissmuth, and H.H. Sitte Concentrative export from the endoplasmic reticulum of the ?-aminobutyric acid transporter 1 requires binding to SEC24D J Biol Chem 282 2007 7679 7689 (Pubitemid 47093672)
55. S. Sucic, A. El-Kasaby, O. Kudlacek, S. Sarker, H.H. Sitte, and P. Marin et al. The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C J Biol Chem 286 2011 16482 16490
56. S. Sucic, F. Koban, A. El-Kasaby, O. Kudlacek, T. Stockner, and H.H. Sitte et al. Switching the clientele: a lysine residing in the C terminus of the serotonin transporter specifies its preference for the coat protein complex II component SEC24C J Biol Chem 288 2013 5330 5341
57. A. Kasaby, H. Just, E. Malle, P.C. Stolt-Bergner, H.H. Sitte, and M. Freissmuth et al. Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter J Biol Chem 285 2010 39201 39210
58. A. Penmatsa, K.H. Wang, and E. Gouaux X-ray structure of dopamine transporter elucidates antidepressant mechanism Nature 503 2013 85 90
59. M. Fujiwara, H. Yamamoto, T. Miyagi, T. Seki, S. Tanaka, and I. Hide et al. Effects of the chemical chaperone 4-phenylbutylate on the function of the serotonin transporter (SERT) expressed in COS-7 cells J Pharmacol Sci 122 2013 71 83
60. M.T. Jacobs, Y.W. Zhang, S.D. Campbell, and G. Rudnick Ibogaine, a noncompetitive inhibitor of serotonin transport, acts by stabilizing the cytoplasm-facing state of the transporter J Biol Chem 282 2007 29441 29447 (Pubitemid 350043359)
61. S. Sucic, S. Dallinger, B. Zdrazil, R. Weissensteiner, T.N. Jørgensen, and M. Holy et al. The N terminus of monoamine transporters is a lever required for the action of amphetamines J Biol Chem 285 2010 10924 10938
62. S. Abdul-Hussein, J. Andréll, and C.G. Tate Thermostabilisation of the serotonin transporter in a cocaine-bound conformation J Mol Biol 425 2013 2198 2207
63. N. Chen, R.A. Vaughan, and M.E. Reith The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis J Neurochem 77 2001 1116 1127 (Pubitemid 32467066)
64. K.J. Linton, and I.B. Holland The ABC transporters of human physiology and disease 2011 World Scientific London
65. R.J. Dawson, and K.P. Locher Structure of a bacterial multidrug abc transporter Nature 443 2006 180 185 (Pubitemid 44387602)
66. M.S. Jin, M.L. Oldham, Q. Zhang, and J. Chen Crystal structure of the multidrug transporter p-glycoprotein from Caenorhabditis elegans Nature 490 2012 566 569
67. S.G. Aller, J. Yu, A. Ward, Y. Weng, S. Chittaboina, and R. Zhuo et al. Structure of p-glycoprotein reveals a molecular basis for poly-specific drug binding Science 323 2009 1718 1722
68. C.A. Shintre, A.C. Pike, Q. Li, J.I. Kim, A.J. Barr, and S. Goubin et al. Structures of abcb10, a human atp-binding cassette transporter in apo- and nucleotide-bound states Proc Natl Acad Sci USA 110 2013 9710 9715
69. A. Ward, C.L. Reyes, J. Yu, C.B. Roth, and G. Chang Flexibility in the abc transporter msba: alternating access with a twist Proc Natl Acad Sci USA 104 2007 19005 19010
70. K. Hollenstein, R.J. Dawson, and K.P. Locher Structure and mechanism of abc transporter proteins Curr Opin Struct Biol 17 2007 412 418 (Pubitemid 47451766)
71. A.A. Komar A pause for thought along the co-translational folding pathway Trends Biochem Sci 34 2009 16 24
72. R.R. Singaraja, H. Visscher, E.R. James, A. Chroni, J.M. Coutinho, and L.R. Brunham et al. Specific mutations in abca1 have discrete effects on abca1 function and lipid phenotypes both in vivo and in vitro Circ Res 99 2006 389 397 (Pubitemid 44253695)
73. B. Sorrenson, R.J. Suetani, M.J. Williams, V.M. Bickley, P.M. George, and G.T. Jones et al. Functional rescue of mutant abca1 proteins by sodium 4-phenylbutyrate J Lipid Res 54 2013 55 62
74. N. Cheong, M. Madesh, L.W. Gonzales, M. Zhao, K. Yu, and P.L. Ballard et al. Functional and trafficking defects in atp binding cassette a3 mutants associated with respiratory distress syndrome J Biol Chem 281 2006 9791 9800 (Pubitemid 43864698)
75. J. Gautherot, A.M. Durand-Schneider, D. Delautier, J.L. Delaunay, A. Rada, and J. Gabillet et al. Effects of cellular, chemical, and pharmacological chaperones on the rescue of a trafficking-defective mutant of the atp-binding cassette transporter proteins abcb1/abcb4 J Biol Chem 287 2012 5070 5078
76. H. Hayashi, T. Takada, H. Suzuki, H. Akita, and Y. Sugiyama Two common pfic2 mutations are associated with the impaired membrane trafficking of bsep/abcb11 Hepatology 41 2005 916 924 (Pubitemid 40462954)
77. K. Hashimoto, T. Uchiumi, T. Konno, T. Ebihara, T. Nakamura, and M. Wada et al. Trafficking and functional defects by mutations of the atp-binding domains in mrp2 in patients with Dubin-Johnson syndrome Hepatology 36 2002 1236 1245 (Pubitemid 35253441)
78. M. Hirouchi, H. Suzuki, M. Itoda, S. Ozawa, J. Sawada, and I. Ieiri et al. Characterization of the cellular localization, expression level, and function of snp variants of mrp2/abcc2 Pharm Res 21 2004 742 748 (Pubitemid 39011294)
79. O. Le Saux, K. Fulop, Y. Yamaguchi, A. Ilias, Z. Szabo, and C.N. Brampton et al. Expression and in vivo rescue of human abcc6 disease-causing mutants in mouse liver PLoS ONE 6 2011 e24738
80. D.M. Green, K.E. McDougal, S.M. Blackman, P.R. Sosnay, L.B. Henderson, K.M. Naughton, J.M. Collaco, and G.R. Cutting Mutations that permit residual cftr function delay acquisition of multiple respiratory pathogens in cf patients Respir Res 11 2010 140
81. E. Kerem Pharmacological induction of cftr function in patients with cystic fibrosis: mutation-specific therapy Pediatric Pulmonol 40 3 2005 183 196 (Pubitemid 41254489)
82. S. Tornovsky, A. Crane, K.E. Cosgrove, K. Hussain, J. Lavie, and M. Heyman et al. Hyperinsulinism of infancy: novel abcc8 and kcnj11 mutations and evidence for additional locus heterogeneity J Clin Endocrinol Metab 89 2004 6224 6234 (Pubitemid 39628437)
83. Y. Imai, M. Nakane, K. Kage, S. Tsukahara, E. Ishikawa, and T. Tsuruo et al. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance Mol Cancer Ther 1 2002 611 616
84. J.K. Myers, L.A. Beihoffer, and C.R. Sanders Phenotology of disease-linked proteins Hum Mut 25 2005 90 97 (Pubitemid 40075918)
85. S.H. Cheng, R.J. Gregory, J. Marshall, S. Paul, D.W. Souza, and G.A. White et al. Defective intracellular transport and processing of cftr is the molecular basis of most cystic fibrosis Cell 63 1990 827 834 (Pubitemid 120035055)
86. D.P. Rich, M.P. Anderson, R.J. Gregory, S.H. Cheng, S. Paul, and D.M. Jefferson et al. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells Nature 347 1990 358 363
87. X. Wang, J. Venable, P. LaPointe, D.M. Hutt, A.V. Koulov, and J. Coppinger et al. 3rd, Balch WE. Hsp90 cochaperone aha1 downregulation rescues misfolding of cftr in cystic fibrosis Cell 127 2006 803 815 (Pubitemid 44716255)
88. J.M. Younger, L. Chen, H.Y. Ren, M.F. Rosser, E.L. Turnbull, and C.Y. Fan et al. Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator Cell 126 2006 571 582 (Pubitemid 44163603)
89. J. Cameron, T. Ranheim, B. Halvorsen, M.A. Kulseth, T.P. Leren, and K.E. Berge Tangier disease caused by compound heterozygosity for abca1 mutations r282x and y1532c Atherosclerosis 209 2010 163 166
90. C. Albrecht, J.H. McVey, J.I. Elliott, A. Sardini, I. Kasza, and A.D. Mumford et al. A novel missense mutation in abca1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome Blood 106 2005 542 549 (Pubitemid 40981249)
91. J.L. Delaunay, A.M. Durand-Schneider, D. Delautier, A. Rada, J. Gautherot, and E. Jacquemin et al. A missense mutation in abcb4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature Hepatology 49 2009 1218 1227
92. J.A. Byrne, S.S. Strautnieks, G. Ihrke, F. Pagani, A.S. Knisely, and K.J. Linton et al. Missense mutations and single nucleotide polymorphisms in abcb11 impair bile salt export pump processing and function or disrupt pre-messenger rna splicing Hepatology 49 2009 553 567
93. V. Keitel, J. Kartenbeck, A.T. Nies, H. Spring, M. Brom, and D. Keppler Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome Hepatology 32 2000 1317 1328
94. V. Keitel, A.T. Nies, M. Brom, J. Hummel-Eisenbeiss, H. Spring, and D. Keppler A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of mrp2 (abcc2) Am J Physiol Gastrointest Liver Physiol 284 2003 G165 G174
95. K. Fülöp, L. Barna, O. Symmons, P. Zavodszky, and A. Varadi Clustering of disease-causing mutations on the domain-domain interfaces of abcc6 Biochem Biophys Res Commun 379 2009 706 709
96. O.M. Woodward, D.N. Tukaye, J. Cui, P. Greenwell, L.M. Constantoulakis, and B.S. Parker et al. Gout-causing q141k mutation in abcg2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules Proc Natl Acad Sci USA 110 2013 5223 5228
97. H. Nakagawa, Y. Toyoda, K. Wakabayashi-Nakao, H. Tamaki, M. Osumi, and T. Ishikawa Ubiquitin-mediated proteasomal degradation of abc transporters: a new aspect of genetic polymorphisms and clinical impacts J Pharm Sci 100 2011 3602 3619
98. P.B. Davis, U. Yasothan, and P. Kirkpatrick Ivacaftor Nat Rev Drug Discov 11 2012 349 350
99. R.S. Pettit Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment Ann Pharmacother 46 2012 1065 1075
100. E. Gonzales, B. Grosse, D. Cassio, A. Davit-Spraul, M. Fabre, and E. Jacquemin Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2 J Hepatol 57 2012 695 698
101. O. Polgar, R.W. Robey, K. Morisaki, M. Dean, C. Michejda, and Z.E. Sauna et al. Mutational analysis of abcg2: role of the gxxxg motif Biochemistry 43 2004 9448 9456 (Pubitemid 38955477)
102. N. Pedemonte, G.L. Lukacs, K. Du, E. Caci, O. Zegarra-Moran, and L.J. Galietta et al. Small-molecule correctors of defective deltaf508-cftr cellular processing identified by high-throughput screening J Clin Invest 115 2005 2564 2571 (Pubitemid 41266219)
103. T.W. Loo, M.C. Bartlett, and D.M. Clarke Rescue of folding defects in abc transporters using pharmacological chaperones J Bioenerg Biomembr 37 2005 501 507 (Pubitemid 43725183)
104. S.H. Iram, and S.P. Cole Mutation of glu521 or glu535 in cytoplasmic loop 5 causes differential misfolding in multiple domains of multidrug and organic anion transporter mrp1 (abcc1) J Biol Chem 287 2012 7543 7555
105. T. Kato, H. Hayashi, and Y. Sugiyama Short- and medium-chain fatty acids enhance the cell surface expression and transport capacity of the bile salt export pump (bsep/abcb11) Biochim Biophys Acta 1801 2010 1005 1012
106. T. Misawa, H. Hayashi, M. Makishima, Y. Sugiyama, and Y. Hashimoto E297g mutated bile salt export pump (bsep) function enhancers derived from gw4064: structural development study and separation from farnesoid X receptor-agonistic activity Bioorg Med Chem Lett 22 2012 3962 3966
107. T. Misawa, H. Hayashi, Y. Sugiyama, and Y. Hashimoto Discovery and structural development of small molecules that enhance transport activity of bile salt export pump mutant associated with progressive familial intrahepatic cholestasis type 2 Bioorg Med Chem 20 2012 2940 2949
108. H. Hayashi, and Y. Sugiyama 4-Phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps Hepatology 45 2007 1506 1516 (Pubitemid 46918335)